Effects of an HIV Peer Prevention Intervention on Sexual and Injecting Risk Behaviors Among Injecting Drug Users and Their Risk Partners in Thai Nguyen, Vietnam: a Randomized Controlled Trial
Overview
Authors
Affiliations
Globally, 30% of new HIV infections outside sub-Saharan Africa involve injecting drug users (IDU) and in many countries, including Vietnam, HIV epidemics are concentrated among IDU. We conducted a randomized controlled trial in Thai Nguyen, Vietnam, to evaluate whether a peer oriented behavioral intervention could reduce injecting and sexual HIV risk behaviors among IDU and their network members. 419 HIV-negative index IDU aged 18 years or older and 516 injecting and sexual network members were enrolled. Each index participant was randomly assigned to receive a series of six small group peer educator-training sessions and three booster sessions in addition to HIV testing and counseling (HTC) (intervention; n = 210) or HTC only (control; n = 209). Follow-up, including HTC, was conducted at 3, 6, 9 and 12 months post-intervention. The proportion of unprotected sex dropped significantly from 49% to 27% (SE (difference) = 3%, p < 0.01) between baseline and the 3-month visit among all index-network member pairs. However, at 12 months, post-intervention, intervention participants had a 14% greater decline in unprotected sex relative to control participants (Wald test = 10.8, df = 4, p = 0.03). This intervention effect is explained by trial participants assigned to the control arm who missed at least one standardized HTC session during follow-up and subsequently reported increased unprotected sex. The proportion of observed needle/syringe sharing dropped significantly between baseline and the 3-month visit (14% vs. 3%, SE (difference) = 2%, p < 0.01) and persisted until 12 months, but there was no difference across trial arms (Wald test = 3.74, df = 3, p = 0.44).
Mackesy-Amiti M, Bahromov M, Levy J, Jonbekov J, Luc C J Int AIDS Soc. 2024; 27 Suppl 3:e26310.
PMID: 39030891 PMC: 11258451. DOI: 10.1002/jia2.26310.
Prata Menezes N, Mehta S, Wesolowski A, Clipman S, Srikrishnan A, Kumar M Addiction. 2023; 119(3):570-581.
PMID: 37967827 PMC: 11003398. DOI: 10.1111/add.16379.
Hernandez-Ramirez R, Spiegelman D, Lok J, Forastiere L, Friedman S, Latkin C AIDS Behav. 2023; 28(1):225-237.
PMID: 37932493 PMC: 11062514. DOI: 10.1007/s10461-023-04213-x.
Bose D, Hundal A, Singh S, Singh S, Seth K, Ul Hadi S Campbell Syst Rev. 2023; 19(1):e1297.
PMID: 36911864 PMC: 9831290. DOI: 10.1002/cl2.1297.
Chang J, Shelly S, Busz M, Stoicescu C, Iryawan A, Madybaeva D Harm Reduct J. 2021; 18(1):15.
PMID: 33536033 PMC: 7857348. DOI: 10.1186/s12954-021-00461-z.